Cardiac Patient’s Nursing Care Plan Essay
What additional history would you obtain from this patient?
In the case under discussion, the patient has no significant cardiac, hypertension, and dyslipidemia history. After the placement of a drug-eluting stent (DES), slight lipid elevation and high blood pressure are observed. Therefore, it is required to pay attention to additional history to be obtained from the patient. If no clear information is given in his medical history, communication with the man should give certain results.
First, it is necessary to clarify if chest pain has ever bothered the man. The focus on such conditions as fatigue, the lack of unreasonable loss of energy, and depression plays an important role as well. Regarding the fact that the patient is obese and hypertensive, it is reasonable to ask if there is a diabetes history in his family (Baumann et al., 2016). However, hypertension (systolic is about 136 and higher, and diastolic is about 81 and higher) after stent placement is a normal thing according to Khoury et al. (2018). Therefore, it is recommended to obtain some general facts about the patient, including his dietary habits, attitudes to physical activities, allegories, and past surgeries or treatment plans if any were offered.Cardiac Patient’s Nursing Care Plan Essay
What choice of drugs, dose would you include in your plan of care? And for how long?
Control of hypertension is an important step in this care plan. For example, b-blockers and ACE-Is should be included (“Clinical practice guidelines,” 2014). These drugs can also reduce the size of a potential infarct in the future. For example, the patient should take metoprolol 25 mg daily as the initiation dose and 100 mg as the target dose (“Clinical practice guidelines,” 2014). This drug should be taken seven days after discharge with the required follow-up to identify the changes.Cardiac Patient’s Nursing Care Plan Essay
Give the rationale for your drug choice. In general, the therapy for post-STEMI patients is based on several types of drugs being taken at the same time. First, hypertension control cannot be ignored. The fact that the patient is obese also determines care. Finally, the condition of the blood should be regulated. The rationale for these drugs’ choice remains clear. The patient has to control his physical condition and avoid serious complications after the placement of the DES. There is a thought that lean patients are exposed to a greater risk of complications in comparison to obese patients (Numasawa et al., 2015). However, obesity is also a cause of multiple cardiovascular complications. Therefore, it is necessary not to allow new problems and changes being developed after the stent placement.